May 20, 2009
The United States and 16 states have joined in two whistleblower suits that allege that Wyeth, a drug manufacturer, Wyeth, failed to pay rebates they were required to make to the Medicaid program. Two drugs, Protonix Oral and Protonix IV, used to suppress stomach acid, are at issue in the suits.
Wyeth offered deep discounts to hospitals that used the drugs and failed to report those discounts to the government and to give the government the same discounts.
California, Delaware, the District of Columbia, Florida, Illinois, Indiana, Louisiana, Massachusetts, New York, Michigan, Nevada, New Hampshire, Tennessee, Texas, Virginia and Wisconsin also have intervened in the whistleblower suits against Wyeth.